NO963749L - Transdermalt system i form av et plaster med et tamoxifen-derivat - Google Patents

Transdermalt system i form av et plaster med et tamoxifen-derivat

Info

Publication number
NO963749L
NO963749L NO963749A NO963749A NO963749L NO 963749 L NO963749 L NO 963749L NO 963749 A NO963749 A NO 963749A NO 963749 A NO963749 A NO 963749A NO 963749 L NO963749 L NO 963749L
Authority
NO
Norway
Prior art keywords
patch
transdermal system
tamoxifen derivative
tamoxifen
derivative
Prior art date
Application number
NO963749A
Other languages
English (en)
Other versions
NO963749D0 (no
Inventor
Wilfried Fischer
Karin Klokkers
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of NO963749D0 publication Critical patent/NO963749D0/no
Publication of NO963749L publication Critical patent/NO963749L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Et transdermalt system i form av et plaster som omfatter et tamoksifenderivat, samt en resorpsjonsbefordrende til- setning for systemisk administrering.
NO963749A 1994-03-08 1996-09-06 Transdermalt system i form av et plaster med et tamoxifen-derivat NO963749L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4407742A DE4407742C1 (de) 1994-03-08 1994-03-08 Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
PCT/EP1995/000603 WO1995024187A1 (de) 1994-03-08 1995-02-20 Transdermales system in form eines pflasters mit einem tamoxifen-derivat

Publications (2)

Publication Number Publication Date
NO963749D0 NO963749D0 (no) 1996-09-06
NO963749L true NO963749L (no) 1996-11-01

Family

ID=6512191

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963749A NO963749L (no) 1994-03-08 1996-09-06 Transdermalt system i form av et plaster med et tamoxifen-derivat

Country Status (12)

Country Link
US (1) US5904930A (no)
EP (1) EP0748218B1 (no)
JP (1) JPH09509948A (no)
AT (1) ATE203667T1 (no)
AU (1) AU694184B2 (no)
CA (1) CA2185016A1 (no)
DE (2) DE4407742C1 (no)
FI (1) FI963515A0 (no)
NO (1) NO963749L (no)
PL (1) PL316177A1 (no)
WO (1) WO1995024187A1 (no)
ZA (1) ZA951880B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002531534A (ja) * 1998-12-04 2002-09-24 マックス−デルブルック−セントラム フュール モレクラーレ メディツィン タモキシフェン含有リポソーム系腫瘍治療剤
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
KR20020013533A (ko) 1999-05-04 2002-02-20 앤드류 맥린 안드로겐 글리코사이드와 그것의 안드로겐 활성
CO5170459A1 (es) * 1999-06-01 2002-06-27 Pfizer Prod Inc Terapia transdermica con agonistas-antagonistas de estrogenos len-ol, administrados mediante medios transdermicos
CO5271709A1 (es) * 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos
US6815074B2 (en) 2001-05-30 2004-11-09 Novartis Ag Polymeric materials for making contact lenses
US8586079B2 (en) * 2002-06-21 2013-11-19 Graphic Productions Inc. Promotional simulation for transdermal patch sampler
US7485623B2 (en) 2002-12-18 2009-02-03 Laboratoires Besins International Sa Reduction of breast density with 4-hydroxy tamoxifen
JP5490346B2 (ja) 2003-04-01 2014-05-14 ブザン ヘルスケア ルクセンブルグ エスアーエールエル ４−ヒドロキシタモキシフェンによる乳癌の予防および治療
US7968532B2 (en) 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
EP1579857A1 (en) 2004-03-22 2005-09-28 Laboratoires Besins International Chemically stable compositions of 4-hydroxy tamoxifen
JP5072588B2 (ja) * 2004-03-22 2012-11-14 ラボラトワール ブザン アンテルナスィヨナル ４−ヒドロキシタモキシフェンを用いた良性乳房疾患の治療および予防
EP1579856A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
FR2870125B1 (fr) * 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
WO2010034053A1 (en) * 2008-09-26 2010-04-01 Suzana Hillhouse Transdermal delivery device and method
EP3656376A1 (en) * 2008-12-11 2020-05-27 Besins Healthcare Luxembourg SARL Transdermal pharmaceutical compositions comprising a serm
US11624095B2 (en) 2017-09-27 2023-04-11 Case Western Reserve University Method of quantifying HIV reservoirs by induced transcription based sequencing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560274A (en) * 1977-02-28 1980-02-06 Ici Ltd Phenylbut 1-ene derivatives having antiostrogenicactivity
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
GB8604528D0 (en) * 1986-02-24 1986-04-03 Ici Plc Therapeutic agents
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
EP0287690B1 (de) * 1987-04-21 1992-09-02 HEUMANN PHARMA GMBH & CO Stabile Lösungsmitteladdukte von Z-1-(p-beta-Dimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl)-2-phenylbut-1-en
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5229130A (en) * 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
GB2273873A (en) * 1992-12-23 1994-07-06 Univ Sheffield Treatment of psoriasis

Also Published As

Publication number Publication date
FI963515A (fi) 1996-09-06
US5904930A (en) 1999-05-18
EP0748218A1 (de) 1996-12-18
JPH09509948A (ja) 1997-10-07
AU1810695A (en) 1995-09-25
PL316177A1 (en) 1996-12-23
DE4407742C1 (de) 1995-06-22
AU694184B2 (en) 1998-07-16
FI963515A0 (fi) 1996-09-06
NO963749D0 (no) 1996-09-06
ATE203667T1 (de) 2001-08-15
DE59509470D1 (de) 2001-09-06
ZA951880B (en) 1995-12-11
CA2185016A1 (en) 1995-09-14
WO1995024187A1 (de) 1995-09-14
EP0748218B1 (de) 2001-08-01

Similar Documents

Publication Publication Date Title
NO963749L (no) Transdermalt system i form av et plaster med et tamoxifen-derivat
NO931209L (no) Anordning for tarnsdermal tilfoersel av kontraseptiver
DK68991D0 (da) Manifold
ES2148223T3 (es) Taxol encapsulado en liposomas y metodo para su uso.
FI871750A0 (fi) Nasal administration av laekemedel.
NL184999B (nl) Pleister met werking tegen pijn en ontstekingen.
NL300136I1 (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
NO971568L (no) Analoger av keratinocyttvekstfaktor
SG139553A1 (en) 7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereof
KR890017767U (ko) 연료 송출관
DE59308292D1 (de) Substituierte triole
DK1112060T3 (da) Doseringsform anvendende flydende formulering
ES2113740T3 (es) Maquina para igualar hormigon.
DE69731882D1 (de) Transdermal verabreichtes dextromethorphan als hustenmittel
FI965193A (fi) Triterpeenijohdannainen ja lääkeseos
NO892032L (no) Anordning for befestigelse av stokkskinner i penser og fremgangsmaate for bruk av anordningen.
DK0910379T3 (da) Plaster til transdermal påføring af pergolid
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
RU1813837C (ru) Напорный подземный водовод дл массива с наклонным тектоническим разломом
NO931208L (no) Formuleringer for transdermale kontraseptiver, samt fremgangsmaater og innretninger for tilfoersel av slike
FI944127A (fi) Elektrokemiallinen menetelmä ja laite lääkkeen antamiseen
SE8401376D0 (sv) Sett och anordning i samband med fotbroms pa trampcykel
DE59712215D1 (de) Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination
IT215129Z2 (it) Profilattico per uso sia maschile che femminile
IT8322175A0 (it) Derivati chinossalinonici e1,5-benzodiazepinonici farmacologicamente attivi.